Osteoporotic fractures are a major source of morbidity, mortality, and cost in older adults. Because fracture risk increases exponentially with age, multimorbidity is the norm for most older adults and can complicate assessment of the risks and benefits of osteoporosis screening and treatment. One of the most common but understudied such comorbidities is chronic kidney disease (CKD).Older adults with CKD have a greater risk of death at worsening levels of kidney function than those without CKD. Because impaired kidney function reduces bone quality and increases risk of falls, CKD has also been associated with fractures, although prior studies did not take into account competing mortality risk, which can bias fracture risk prediction. Furthermore, it is unknown whether CKD in an older adult with mild, age‐related decline in kidney function independently increases the risk of fracture or whether the presence of CKD is merely a marker of other chronic illnesses associated with fracture. Precise estimates of the risk of fracture at all levels of CKD, accounting for competing mortality risk and other risk factors, are therefore needed. Finally, we have insufficient evidence to understand whether race or ethnicity modifies the fracture risk associated with CKD. This is especially important because
Journal of American Geriatrics Society – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera